Impact and cost-effectiveness of SARS-CoV-2 self-testing strategies in schools: a multicountry modelling analysis.
COVID-19
Health economics
Health policy
Journal
BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874
Informations de publication
Date de publication:
27 Feb 2024
27 Feb 2024
Historique:
medline:
1
3
2024
pubmed:
29
2
2024
entrez:
28
2
2024
Statut:
epublish
Résumé
To determine the most epidemiologically effective and cost-effective school-based SARS-CoV-2 antigen-detection rapid diagnostic test (Ag-RDT) self-testing strategies among teachers and students. Mathematical modelling and economic evaluation. Simulated school and community populations were parameterised to Brazil, Georgia and Zambia, with SARS-CoV-2 self-testing strategies targeted to teachers and students in primary and secondary schools under varying epidemic conditions. SARS-CoV-2 Ag-RDT self-testing strategies for only teachers or teachers and students-only symptomatically or symptomatically and asymptomatically at 5%, 10%, 40% or 100% of schools at varying frequencies. Outcomes were assessed in terms of total infections and symptomatic days among teachers and students, as well as total infections and deaths within the community under the intervention compared with baseline. The incremental cost-effectiveness ratios (ICERs) were calculated for infections prevented among teachers and students. With respect to both the reduction in infections and total cost, symptomatic testing of all teachers and students appears to be the most cost-effective strategy. Symptomatic testing can prevent up to 69·3%, 64·5% and 75·5% of school infections in Brazil, Georgia and Zambia, respectively, depending on the epidemic conditions, with additional reductions in community infections. ICERs for symptomatic testing range from US$2 to US$19 per additional school infection averted as compared with symptomatic testing of teachers alone. Symptomatic testing of teachers and students has the potential to cost-effectively reduce a substantial number of school and community infections.
Identifiants
pubmed: 38417953
pii: bmjopen-2023-078674
doi: 10.1136/bmjopen-2023-078674
pmc: PMC10900377
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e078674Subventions
Organisme : World Health Organization
ID : 001
Pays : International
Informations de copyright
© Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
Déclaration de conflit d'intérêts
Competing interests: None declared.
Références
CMAJ Open. 2022 Dec 6;10(4):E1027-E1033
pubmed: 36622324
BMJ. 2022 Mar 9;376:e069761
pubmed: 35264324
Lancet. 2021 Oct 2;398(10307):1217-1229
pubmed: 34534517
Nat Genet. 2023 Jan;55(1):26-33
pubmed: 36624344
BMJ Glob Health. 2021 Jul;6(Suppl 4):
pubmed: 34275874
JAMA Netw Open. 2023 Feb 1;6(2):e2255599
pubmed: 36790812
Global Health. 2022 Jan 22;18(1):5
pubmed: 35065670
J Sch Health. 2022 May;92(5):445-451
pubmed: 35156210
BMC Public Health. 2021 Jan 12;21(1):125
pubmed: 33430832
Nat Commun. 2022 Mar 1;13(1):1106
pubmed: 35232987
Lancet Child Adolesc Health. 2021 Jun;5(6):428-436
pubmed: 33751952
PLoS Med. 2021 Aug 12;18(8):e1003735
pubmed: 34383750
Elife. 2022 Nov 16;11:
pubmed: 36383192
Elife. 2022 Jul 05;11:
pubmed: 35787310
EClinicalMedicine. 2022 Jan;43:101230
pubmed: 34927038
Clin Infect Dis. 2023 Feb 18;76(4):620-630
pubmed: 36208211